North America
Biosimilars Market Study Analysis:
Size
of the North America Biosimilars Market size was valued at USD 2 million in
2018 and this figure estimated to cross USD 13 Million by the end of 2025, and
it is growing at a CAGR of 31.19% during the forecast period 2019-2025. Biosimilars
are formed by using living cells that treat disease, by recombinant DNA
technology and controlled gene expression. Largest biosimilars are derived from
bacteria, viruses, plants, and animals. Biosimilar drugs are used in the prevention
and cure of various diseases such as rheumatoid arthritis, cancer, chronic
kidney failure, oncology, diabetes, heart attacks, autoimmune diseases, growth
hormone deficiency, and infectious disease.
Browse details of 140 number of the pages research report
developed in North America
Biosimilars Market Research Report @ https://www.researchcosmos.com/reports/north-america-biosimilars-market/72699030
Drivers and
Restraints:
Biosimilars
are beginning as one of the most important sectors in the healthcare industry.
With growing healthcare costs, biosimilars are being looked upon as an
affordable treatment option. Growing prosperity is observing comprehensive
growth in biosimilars industry from demanding clinical needs of therapeutics. A rise in GDP and healthcare expenditures, and the demand for cost-effective
therapeutics solution has resulted in the growth of this market in North
America.
Major
parts that are driving the market growth are next-gen business, high growth in
chronic diseases, and less cost biosimilar drugs. Still, high initial
investments in research hinder the growth of the protein expression market.
Biosimilars
offer a poorer alternative for other biological and synthetic drugs. Extended
co-operation between manufacturing companies and the outsourcing of biosimilar
products are acting as a reason for the market demand. Still, high
manufacturing cost and complexity, and the availability of low-priced generic
drugs in the market are some of the major restraints the market is facing.
Numerous companies are fraught with approvals for their biosimilar drugs, due
to unavailability of favorable regulatory compliance and heavy opposition from
the reference product manufacturers. Moreover, consumer preferences and the
prescription patterns of physicians in the United States are more inclined
towards reference products.
Ask Free Sample of the Report @ https://www.researchcosmos.com/request/north-america-biosimilars-market/72699030
Geographical Insights:
Based
on geography, the North American market is analyzed in the regions of Canada
and the United States. North America is expected to lead this market during the
forecast period due to increasing efforts by manufacturers to take advantage of
growth opportunities in the United States and Canada. The FDA in the USA
approved the first biosimilar product, Zarxio (filgrastim-side), in March 2015.
The United States biosimilar regulatory route was created in March 2009 and
since then the region has gained significant momentum, presenting new
opportunities and challenges.
Key Players Profiled
in this North America Biosimilars Market report are: Wockhardt Ltd, Sandoz
International GmbH, Hospira, Inc., Teva Pharmaceutical Industries Ltd., Biocon
Limited, Dr. Reddy’s Laboratories, Zydus Cadila, Mylan Inc., Celltrion Inc.,
Roche Diagnostics and Cipla Ltd.
For any queries, inquire more @ https://www.researchcosmos.com/inquire/north-america-biosimilars-market/72699030
About
Us:
Research Cosmos is a provider of standard and customized
Industry research, business intelligence and consulting services across more
than 100 domains in different industries of the world. We host the trending
Industry reports of the world’s top-notch publishing companies, offering
services to a wide range of customers from students to fortune 500 companies
and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
www.researchcosmos.com
+1 888 709 8757
https://marketreportsweb.com/
https://acutemarketinsights.com/
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
www.researchcosmos.com
+1 888 709 8757
https://marketreportsweb.com/
https://acutemarketinsights.com/
No comments:
Post a Comment